Tag

Bliss GVS Pharma

1 article

Anupam Rasayan Q2 PAT Up 14% YoY

Anupam Rasayan reported Q2FY27 standalone PAT of ₹65 Cr, up 14% YoY, with revenue growth of 11% to ₹821 Cr. EBITDA margin expanded significantly to 25% in Q2FY27 from 19% in Q2FY26, driven by operatio